Ignite Creation Date:
2024-05-05 @ 5:29 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00461084
Status:
COMPLETED
Last Update Posted:
2014-09-18
First Post:
2007-04-13
Brief Title:
Biaxin Based Antibiotic Therapy in Previously Untreated Advanced Stage Indolent Lymphoma
Sponsor:
Organization:
Memorial Sloan Kettering Cancer Center
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITHOUT_DNA
Bio Spec Description:
tissue and whole blood
Enrollment Count:
36
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 3210 |
Who Masked List: